Day One Biopharmaceuticals Overview

Day One Biopharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for DAWN.

Quarterly EBIT

-$23.25M

↑ 64.41% YoY

As of Dec 31, 2025

Annual EBIT (TTM)

-$119.99M

↑ 44.78% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin